Elixirr International PLC
LSE:ELIX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/FCFE
Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.
Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.
Valuation Scenarios
If P/FCFE returns to its 3-Year Average (15.8), the stock would be worth GBX1 145.63 (58% upside from current price).
| Scenario | P/FCFE Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 10 | GBX726 |
0%
|
| 3-Year Average | 15.8 | GBX1 145.63 |
+58%
|
| 5-Year Average | 18.2 | GBX1 324.88 |
+82%
|
| Industry Average | 0.2 | GBX12.25 |
-98%
|
| Country Average | 0.2 | GBX14.87 |
-98%
|
Forward P/FCFE
Today’s price vs future free cash flow to equity
Peer Comparison
| Market Cap | P/FCFE | P/E | ||||
|---|---|---|---|---|---|---|
| UK |
|
Elixirr International PLC
LSE:ELIX
|
350.2m GBP | 10 | 18.9 | |
| UK |
|
Relx PLC
LSE:REL
|
49.1B GBP | 17.5 | 23.8 | |
| UK |
I
|
IHS Markit Ltd
F:0M3
|
37.9B EUR | 60 | 36.5 | |
| CA |
|
Thomson Reuters Corp
TSX:TRI
|
57.8B CAD | 36.7 | 27.8 | |
| IE |
|
Experian PLC
LSE:EXPN
|
25B GBP | 23 | 24.8 | |
| US |
|
Verisk Analytics Inc
NASDAQ:VRSK
|
25.1B USD | 9.1 | 27.6 | |
| CH |
|
SGS SA
SIX:SGSN
|
16.3B CHF | 9.9 | 24.6 | |
| US |
|
Equifax Inc
NYSE:EFX
|
20.7B USD | 14 | 29.7 | |
| US |
|
Leidos Holdings Inc
NYSE:LDOS
|
18.9B USD | 13.1 | 13 | |
| US |
U
|
UL Solutions Inc
NYSE:ULS
|
18.4B USD | 0 | 0 | |
| NL |
|
Wolters Kluwer NV
AEX:WKL
|
15B EUR | 7.3 | 11.5 |
Market Distribution
| Min | 0 |
| 30th Percentile | 0.1 |
| Median | 0.2 |
| 70th Percentile | 0.4 |
| Max | 901.8 |
Other Multiples
Elixirr International PLC
Glance View
Elixirr International Plc provides management consultancy services. The firm is principally engaged in the provision of consulting services, delivering and bespoke solutions to a globally recognized client base, including creative and marketing services. The Company’s operating subsidiaries in the United Kingdom include Elixirr Consulting Limited, Elixirr Consulting Services Limited, Elixirr Creative Limited, Den Creative Limited and Coast Digital Limited. The firm also has an operating subsidiary in the United States (Elixirr LLC) and foreign branches in South Africa and Australia.
